Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterol

Christian Labenz, Jürgen H. Prochaska, Yvonne Huber, Michael Nagel, Beate Straub, Philipp Wild, Peter R. Galle & Jörn Schattenberg
Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a prospectively enrolling real-life study cohort to inform physicians on the cardiovascular (CV) event risk based on these changes. A total of 304 patients with histologically confirmed NAFLD were included (mean age, 52...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.